Genzyme inflated its share price by concealing its problems meeting FDA standards, shareholders claim in Boston Federal Court.
Allied Capital Corp. is selling itself too cheaply to Ares Capital, in an all-stock deal valued at $648 million or $3.47 a share, shareholders claim in Montgomery County Court, Md.
Zilog is selling itself too cheaply to Ixys, shareholders say in Santa Clara County Court, Calif.
Categories / Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.
Additional Reads
-
-
Texans head to the polls for high-stakes US Senate primary February 17, 2026